{"url":"https://lda.senate.gov/api/v1/filings/9aed0cfd-114e-41d3-bbd8-440b23c6a67b/","filing_uuid":"9aed0cfd-114e-41d3-bbd8-440b23c6a67b","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2008,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/9aed0cfd-114e-41d3-bbd8-440b23c6a67b/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Paul F. Payette, VP","dt_posted":"2008-04-07T16:07:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1800 Diagonal Road","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":39781,"url":"https://lda.senate.gov/api/v1/registrants/39781/","house_registrant_id":30168,"name":"VAN FLEET ASSOCIATES","description":"Government Relations (Includes Lobbying)","address_1":"1800 Diagonal Road","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22314","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TOWNSEND A. VAN FLEET","contact_telephone":"+1 703-647-7516","dt_updated":"2022-05-27T13:50:23.499184-04:00"},"client":{"id":147320,"url":"https://lda.senate.gov/api/v1/clients/147320/","client_id":1002843,"name":"KIRK PHARMACEUTICALS","general_description":"Pharmaceutical products","client_government_entity":false,"client_self_select":false,"state":"FL","state_display":"Florida","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"FDA and DEA regulation pertaining to over the counter drug sales.","foreign_entity_issues":"","lobbyists":[],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}